Settlement closes legacy; core strong, but PAT crushed by ₹5,000Cr NMC hit
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Mgmt maintained FY27 guidance (12–14% credit growth, 10–12% deposits, 2.75–2.95% NIM). Did NOT upgrade despite Q1 beating guidance on advances/deposits. NMC settlement was a surprise not flagged in annual report; suggests governance oversight.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Core franchise is robust—17.4% advance growth, ₹30.5L crore global business, top-quartile asset quality YoY. However, ₹5,250 Cr NMC settlement crushed PAT (-53% YoY); sequential AQ deterioration (despite mgmt's write-off rationale) and ₹12k-Cr ECL overhang (110 bps CRAR drag) are material headwinds. Management's defensive tone on settlement and refusal to upgrade guidance despite "strongest growth in many quarters" signals caution. Verdict hinges on Q2–Q4 ROA recovery and deposit cost moderation.
₹35114.5 Cr
Revenue · +6.8% YoY₹1572.6 Cr
Reported PAT · −53.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strongest credit growth in many quarters at 17.4% YoY
OVERSTATEDRevenue growth only 6.8% YoY, modest for a ₹30.5L-crore bank; advance growth strong but doesn't translate to top-line
Asset quality benign, GNPA/NPA significantly improved YoY
MISSYoY YoY improvement (GNPA 1.99%, down 29 bps) offset by sequential uptick; write-off conservatism (625 Cr vs 2,200 Cr) masks underlying deterioration
Core profitability metrics strong; NII grew 9.5%
MISSNII growth 9.5% real but compressed by NMC ₹5,250 Cr settlement; net profit ₹1,278 Cr (₹1,572.6 Cr reported) vs ₹5,528 Cr ex-NMC; PAT -53% YoY
CRAR comfortable at 16.3%, better than prior quarter (15.8%)
METCRAR improved QoQ but ECL impact of 110 bps (~₹12,000 Cr) looming from April 2027; per-year amortization 20–22 bps on CRAR drag
Deposit growth 13.8% global, 14.7% domestic indicates strong mobilization
OVERSTATEDGuidance unchanged at 10–12% despite outperformance; mgmt cited geopolitical headwinds and deposit flow to capital markets, indicating caution on sustainability
Earnings quality
What changed since the last call
NMC settlement impact disclosed
NewUSD 600M (~₹5,250 Cr) out-of-court settlement finalized July 1, 2026. Not flagged in annual report; case advanced to trial post-March; settlement deemed "commercially prudent" to avoid prolonged litigation.
ROA guidance downgraded to under watch
DowngradePrior guidance: ROA >1% maintained 17–18 quarters. Q1 delivered 0.25% (1.10% ex-NMC). FY27 full-year guidance deferred; mgmt expects Q2–Q4 ROA >1% but cautious on annual average.
Credit growth guidance NOT raised despite 17.4% Q1
NeutralMaintained 12–14% despite outperformance. Mgmt cited geopolitical headwinds, deposit uncertainty, and need to be cautious on FY-wide sustainability.
ECL impact quantified: 110 bps CRAR (~₹12k Cr), 15–20 bps annual credit cost
NewPrior estimate 125 bps; revised down due to project-loan guideline pullback (50 bps → 15–20 bps). Holdback: ₹2,500 Cr floating provision. Balance spread over 4–5 years.
Capital raise plan reaffirmed; timing flexible
NeutralEquity raise ₹8,500 Cr (medium-term, by Mar 2028); Tier-2 raise ₹6,000 Cr in FY27 (dependent on pricing). Current CRAR 16.3% deemed healthy; no immediate requirement.
The Q&A
Analysts pressed hard on NMC settlement (Joel Rebello, Ashok Ajmera, Kunal Shah): Why settle if no guilt? Why not provision earlier? Why did RBI not flag it? Mgmt deflected with confidentiality, legal advice, and "commercial prudence." Ajmera initially called quarter disappointing; mgmt pushed back forcefully, citing 17.4% advance growth and 13.8% deposit growth as "strongest in many quarters," but analysts noted sequential AQ and fee income declines contradicted. Q&A was tense; mgmt defensive on NMC and margin pressure.
NMC settlement rationale — Joel Rebello, ET
PartialSettlement based on advanced trial stage, legal advice. Stage of trial material. Settlement amount far below oral claims against all parties. No admission of liability. Terms confidential.
Overall quarter assessment — Ashok Ajmera, ICRA
PartialMgmt rejected characterization. Credit growth 17.4% YoY, deposits 13.8%, both "strongest in many quarters." Noted YoY comparison more relevant than QoQ seasonal variance. Asset quality GNPA down YoY; sequential rise due to lower write-offs (conservative) and denominator effect.
Asset quality deterioration — Rikin Shah, ICAP
AnsweredWrite-offs are technical, not economic (100% provisioned). Conservative write-off protects PCR; slight sequential GNPA/NPA rise acceptable. SMA CRILC fell 18 bps → 7 bps, collection efficiency 99.2%. Slippage, recovery better than LY.
NMC case governance and RBI scrutiny — Piyush Shukla, NDTV Profit
DodgedCan't discuss due to confidentiality. International operations significantly reformed since 2021 (governance, CRO/CCO oversight, AML framework strengthened). Domestic book insulated. RBI has strong oversight; Bank compliant with all regs. Case now full and final in ADGM and UK courts.
ECL impact and pricing pass-through — Jayant Kharote, CRISIL
PartialECL impact evolving on fresh flows post-April 1, 2027. Retail loan repricing subject to RBI guidelines (3-year lock norms, creditworthiness trigger). Can reprice back-book under conditions. Industry-wide repricing needed; timing uncertain.
Margin sustainability — Rikin Shah, ICAP
AnsweredNon-MCLR corporate book repricing upward (shifting to MCLR). Bulk deposit cost declined post-FCNR(B) announcement. Asset growth 16–17% will continue margin pressure. Domestic NIM at 2.93%, top-quartile. Guidance 2.75–2.95% maintained.
Deposit stickiness under geopolitical stress — Falaknaaz, Deccan Chronicle
AnsweredCRILC data (>₹5 Cr) improved 0.18% → 0.07%. Slippage lower YoY. Recovery stronger. MSME protected by ECLGS. No stress observed; caution precautionary. Will revisit guidance in Q2 if upside growth continues.
Guidance
Credit growth 12–14% FY27
MediumQ1 delivered 17.4% YoY but not raising guidance. Mgmt cited geopolitical headwinds and deposit volatility. Likely implies H2 slowdown expected or deliberate under-guidance.
NIM 2.75–2.95% FY27
MediumQ1 at 2.77% (domestic 2.93%); in-line. Asset growth 16–17% will pressure margin; offset by repricing and deposit cost normalization. Guidance band wide (20 bps), suggesting uncertainty.
IT budget ₹4,000+ Cr (OPEX + CAPEX combined)
HighOn AI integration (Aditi, Adi tools); branch expansion; tech platform. No specific capex guidance issued for quarter/year.
Risks the call surfaced
Governance / Litigation
HighNMC settlement ₹5,250 Cr resolves trade-finance exposure in Abu Dhabi/UK. Case was sub-judice; settlement without admission. RBI scrutiny ongoing; bank reformed international operations post-2021. Confidentiality clause prevents disclosure of underlying cause. Reputational and regulatory overhang if new details emerge.
Asset Quality / Credit Cost
HighGNPA/NPA rose QoQ despite YoY improvement; mgmt attributes to conservative write-off (625 Cr vs 2,200 Cr LY) and denominator effect, but masks underlying deterioration. ECL migration (Apr 27) will add 110 bps CRAR drag (~₹12k Cr) and 15–20 bps annual credit cost. Geopolitical stress could accelerate slippage in MSME/mid-market segments.
Margin / Deposit Liability
MediumNIM compressed 6 bps QoQ (from 2.83% Mar → 2.77% Jun) despite 9.5% NII growth. Asset growth 16–17% exceeds deposit growth 10–12%, pressuring margin. Bulk deposits (₹2.11L Cr) + CD (₹1.06L Cr) = ₹3.17L Cr of funding at risk if wholesale rates rise or sentiment shifts. Deposit cost at 4.66%, still elevated; geopolitical uncertainty could delay cost decline.
Earnings Quality
MediumFee income fell 47% YoY (commission/exchange/brokerage); other income fell sharply due to treasury revaluation losses (G-sec yield spike 6.10% → 6.78%). Operating profit flat YoY (₹8,127 Cr) despite 9.5% NII growth. Indicates that profitability gains from NII are being offset by income volatility and operational pressures.
Geopolitical / Macro
MediumMgmt cited geopolitical uncertainty as reason for NOT raising credit/deposit guidance despite strong Q1 outperformance. Prolonged trade tensions could dampen MSME/mid-market demand, increase credit cost, and shift depositor preference from bank deposits to capital market investments. RWA expansion may also be impacted.
Management
Score 6/10. Defensive, repetitive on NMC; evasive on governance failures. Clear on numbers but weak on root-cause analysis. Candid on challenges (margin, fee income, ECL) but over-emphasized positives (growth metrics) relative to bottom-line impact. Strong track record on guidance adherence (FY26: beat credit/deposit, met margins/AQ). But Q1 misses on ROA (0.25% vs >1% historical). NMC settlement suggests historical governance failure not immediately resolved. Recovery actions on principal individual ongoing but uncertain.
1 · Q2 FY27 (Sep 2026)
ROA guidance reset; full-year ROA >1% target confirmed or revised downward
2 · April 1, 2027
ECL migration; ₹12k-Cr provision impact begins amortization over 4–5 years
3 · H2 FY27
Deposit market normalization post-geopolitical clarity; FCNR(B) inflows ramp (target ₹4–5B USD by year-end)
Verdict hinges on Q2–Q4 ROA recovery and deposit cost moderation.
Settlement Crushes Profit; Credit Growth Solid But Guidance Caution Signals Headwinds
Reported PAT collapsed 53% due to a ₹5,250-crore NMC settlement, but the underlying business—17.4% credit growth, top-quartile asset quality—is performing well. Management's refusal to raise guidance despite outperformance reveals the real concern: ROA recovery, margin compression, and the looming ECL transition.
₹1,572.6 Cr
-53.1% YoY
₹5,250 Cr
exceptional item
~₹5,500 Cr
+18% YoY (implied)
The quarter's headline numbers mask a paradox: reported profit collapsed 53%, yet the core business posted the strongest credit growth in several quarters at 17.4% and robust deposit mobilization at 13.8%. That gap between headline and organics is the entire story of Q1 FY27.
The settlement: ₹5,250 crores of legacy resolved
On July 1, Bank of Baroda finalized an out-of-court settlement of USD 600 million (~₹5,250 Cr) with NMC Health PLC in Abu Dhabi and UK courts. This trade-finance liability—stemming from a 2017–2019 payment default by NMC, later revealed as a £2 billion fraud—had been sub-judice for years. The bank recorded the full amount as an exceptional item in Q1, reducing reported PAT from an underlying ₹5,500 Cr to ₹1,572.6 Cr. Management framed it as "commercially prudent" and "allowing the bank to focus on sustainable growth," but the timing and lack of prior warning—the annual report had not flagged it—raised immediate questions on governance oversight.
The settlement resolves all claims without any admission of liability or wrongdoings. It allows us to close a legacy matter and focus on customers, stakeholders, and long-term sustainable growth.
What the settlement cost in profit is what it buys in closure: the international operations that generated this exposure have been reshaped since 2021 (governance, AML frameworks, CRO/CCO oversight tightened). The domestic book is insulated. But the governance gap—how such a large contingent liability was not pre-flagged to investors—remains the quarter's deeper discomfort.
Management claims vs. what holds up
Strongest credit growth in many quarters at 17.4% YoY
Revenue ₹35,114.5 Cr, only +6.8% YoY; modest for a ₹30.5L-crore bank. Advance growth strong but doesn't translate to top-line due to low-margin deposit model.
Overstated
Asset quality benign, GNPA/NPA significantly improved YoY
YoY improvement (GNPA -29 bps to 1.99%, NPA -10 bps to 50 bps) real, but masked by sequential rise (QoQ GNPA +19 bps). Write-off conservatism (₹625 Cr vs ₹2,200 Cr LY) defers credit cost recognition.
Contradicted
Core profitability metrics strong; NII grew 9.5%
NII +9.5% real, but operating profit flat YoY (₹8,127 Cr both quarters). Fee income collapsed 47% YoY; treasury income fell 54%. NMC settlement crushes net profit -53% YoY.
Contradicted
Deposit growth 13.8% global, 14.7% domestic indicates strong mobilization
Growth beats guidance (10–12%), but management did NOT raise FY27 guidance. Mgmt cited geopolitical headwinds and deposit flow to capital markets, signaling sustainability concerns.
Overstated
CRAR comfortable at 16.3%, better than prior quarter
16.3% is strong vs peers (up from 15.8% QoQ), but ECL migration (Apr 27) will drag 110 bps (~₹12k Cr) and annual amortization 20–22 bps/year.
Supported (with caveats)
What changed on this call
NMC settlement ₹5,250 Cr finalized and expensed; case fully closed
ROA guidance downgraded to 'under watch'; Q1 delivered 0.25% vs >1% prior target
ECL impact quantified: 110 bps CRAR (~₹12k Cr), 15–20 bps annual credit cost from Apr 27
Credit/deposit guidance maintained at 12–14% / 10–12% FY27 despite Q1 outperformance
Capital raise plan reaffirmed (₹8.5B equity by Mar 28, ₹6B Tier-2 in FY27)
The bull-bear ledger
Advance growth 17.4% YoY, broad-based (retail +18.4%, MSME +20.3%, agri +18.7%)
Asset quality YoY best (GNPA -29 bps, NPA -10 bps)
Slippage 0.91%, credit cost 0.29%, both comfortably within guidance
CRILC SMA improved to 7 bps from 40 bps LY; collection efficiency 99.2%
Domestic NIM 2.93%, top-quartile for PSU banks
Reported PAT -53% YoY; even adjusted, ROA 0.25% vs >1% target
Sequential GNPA/NPA deterioration (QoQ +19 bps GNPA) masked by conservative write-offs
Fee income collapsed 47% YoY; treasury income fell 54% (G-sec volatility)
NIM pressure: margin compressed 6 bps QoQ (2.83% → 2.77%) despite NII +9.5%
ECL transition Apr 27: 110 bps CRAR drag, 15–20 bps annual credit cost
Geopolitical caution cited as reason NOT to raise guidance despite strong growth
Risks, ranked by how much they should concern a holder
Governance / Legacy litigation
HighNMC settlement ₹5,250 Cr resolves trade-finance exposure but signals past underwriting/AML failures. Confidentiality clause prevents full disclosure; RBI scrutiny ongoing. If further penalties or reputational fallout emerge, equity could re-rate lower.
Asset quality deterioration masked
HighSequential GNPA/NPA up QoQ despite write-off conservatism. ECL transition (Apr 27) adds 110 bps CRAR drag and 15–20 bps annual credit cost. If geopolitical stress shocks MSME/mid-market book, slippage could spike above 1.25% guidance.
ROA recovery uncertain
HighQ1 delivered 0.25% vs >1% target. Management deferred FY27 full-year guidance, signaling lack of confidence. If ROA doesn't recover to >1% by Q2, the entire earnings narrative falls apart.
Margin compression / deposit cost stickiness
MediumAsset growth 16–17% exceeds deposit growth 10–12%, pressuring NIM. Bulk deposits (₹2.31L Cr) are rate-sensitive. FCNR(B) mobilization (target ₹4–5B USD) timing uncertain; if delayed, margin recovery pushed to FY28.
Earnings quality / income volatility
MediumFee income -47% YoY, treasury income -54% (G-sec revaluation). Operating profit flat YoY despite 9.5% NII growth. If income volatility persists, reported PAT will continue to disappoint.
The market's verdict (and how it aligns with fundamentals)
The stock has been under pressure since the all-time high of ₹325.5, now down 25.47% at ₹242.6. Post-result (announced July 24), the sell-off accelerated: day-1 drop -0.99%, day-3 -1.26%, day-5 -1.56%. The fact that the initial move did not fade but deteriorated is the market's own reading that this quarter is worse-than-it-looks. The stock now trades below its SMA20 (₹246.15), SMA50 (₹261.24), and SMA200 (₹278.92)—a confirmed downtrend. RSI at 40.9 (neutral-to-weak) suggests room to fall before oversold signals.
Institutional positioning corroborates caution. FII ownership held steady at 9.69% (down just 15 bps from Q3's 9.84%), suggesting no aggressive dumping—but no buying either. DII added 20 bps to 19.01%, a modest defensive tilt, while promoters remained flat at 63.97%. This is not a vote of confidence; it's indifference with a slight domestic institutional hedge.
The debate
The honest read: The bull case overstates the quarter. Credit growth is real, but it's yielding revenue growth of only 6.8% YoY—a disconnect that reflects a low-margin, deposit-heavy business model. Management's tone was defensive on NMC (rightfully so, given governance gaps) and over-assertive on growth (highlighting YoY numbers while downplaying sequential deterioration). ROA miss, margin compression, fee income decline, and the ECL overhang make this a steady-state quarter at best, not a re-rating catalyst. The market's 25% drawdown has absorbed some pain, but more could be in store if Q2 disappoints on ROA or guidance. Verdict: Hold.
What to watch next
1 · Q2 ROA reset (due October 2026)
Management guided for Q2–Q4 ROA >1%, but provided no full-year average. If Q2 delivers <0.8%, it signals structural pressure on margins and fee income—expect further downside.
2 · ECL transition impact (April 1, 2027)
110 bps CRAR drag (~₹12k Cr) beginning Apr 27, amortized over 4–5 years (~20–22 bps annual). Capital raise timing (₹8.5B equity by Mar 28, ₹6B Tier-2 in FY27) and pricing will be critical. Delayed or accretive raise = equity re-rates lower.
3 · Deposit cost normalization & FCNR(B) ramp (H2 FY27)
Bulk deposit cost currently 4.66%, sticky. FCNR(B) mobilization target ₹4–5B USD by year-end (expected to reduce bulk dependency and improve NIM by 15–20 bps). If geopolitical delays deter inflows, margin recovery deferred to FY28.
The number to track from here
Not revenue growth (which doesn't translate to profit), not credit growth (which is real but margin-light). Track ROA. The bank needs to prove it can recover to >1% by Q2, sustain it through Q4, and hit 1%+ as a full-year average despite the ECL headwind. If it can't, the 1% threshold—the psychological floor for any large bank—is breached, and re-rating continues. As of now, Q1's 0.25% ROA and management's defensive tone suggest that threshold is at risk. Watch Q2 for clarity on margin recovery and deposit-cost relief; that's the inflection point.
Bank of Baroda's Q1 FY27 is a tale of divergent optics: strong on credit/deposit growth, weak on profit and ROA, ominous on governance (NMC settlement) and structural headwinds (ECL, margin pressure). The NMC settlement is a closed loop, but sequential asset quality rise, fee income collapse, and ROA miss are not. Management's refusal to raise guidance despite 17.4% credit growth signals internal caution; investors should match it.
The stock's 25% drawdown from ATH has absorbed some of the pain, but more could be in store if Q2 disappoints. Patient holders with an 18–24 month view can wait for ECL migration to stabilize and deposits to normalize; tactical traders should wait for a ROA print >0.8% before adding back. The verdict: steady, not a step-change. Hold until ROA clarity emerges in Q2.